Sanofi leads the way for gene therapy patents: reportLife Sciences Intellectual Property Review (blog)CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall. The IP management compan… Continue reading
Daily MailLAME HORSESDaily MailA third of horses in Britain with a medical problem are lame, which means they struggle to walk because one or more of their legs do not move properly. Many become lame through torn ligaments and tendons, caused by falls,… Continue reading
Medical XpressGerman research advances in cancer and blood disorders reported in human gene therapyMedical XpressThe special focus issue entitled "German Gene Therapy Research—Part 1 ," was developed by Guest Editors Christof von Kalle, MD, … Continue reading
Rare Disease Report (blog)Gene Therapy for HD Continues to Show PromiseRare Disease Report (blog)At the European Society of Gene and Cell Therapy (ESGCT) Congress in Berlin, Germany today, uniQure – the company that developed the first ever approved ge… Continue reading
Broad, DuPont Pioneer Partner to Provide Non-Exclusive Licenses to CRISPR IPGenomeWebNEW YORK (GenomeWeb) – DuPont Pioneer and the Broad Institute announced today that they will jointly provide non-exclusive licenses to CRISPR-Cas9 intellectual propert… Continue reading
Phys.OrgGene therapy can cure lameness in horses, research findsPhys.OrgThe ground-breaking, international study, published in the academic journal Frontiers in Veterinary Science, demonstrated gene therapy using a combination of the Vascular Endotheli… Continue reading
|
From Dr. Jekyll to Mr. Hyde of cancer immunotherapy – Medical Xpress
Medical Xpress Novel immunotherapies can strengthen the body’s own defenses against cancer cells. Treatment of patients with advanced disease can promote partial and … |
PharmaTimes |
GSK, Plasticell Partner to Produce Hematopoietic Cells from iPSCs
Genetic Engineering & Biotechnology News Plasticell will use the bead-based CombiCult platform to produce hematopoietic cells from induced pluripotent stem cells (iPSCs) by optimizing the directed differentiation of the iPSCs to specific blood cell lineages for use by GSK in therapeutic … GSK taps Plasticell’s iPSC differentiation techBioPharma-Reporter.com GSK, Plasticell sign deal to produce haematopoietic cellsPharmaTimes |